Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpanthenol versus zinc oxide for infant diaper rash
IRCT20230606058394N2Phase 4Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexpanthenol and zinc oxide in diaper dermatitis (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Rate of reduction in the number of rashes, Reduction in burning of the child's feet and 1 more. Started Jan 2024; status: completed.
02
Drugs
dexpanthenolzinc oxide
03
Conditions
diaper dermatitis
Beyond the preview
Go deeper on IRCT20230606058394N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230606058394N2.